Theresa May’s deputy accused of misleading MPs after insisting cancer patients have nothing to fear from UK leaving Euratom

Nuclear Industry Association hits back after Damian Green dismisses doctors’ warnings about loss of imported isotopes as 'scaremongering'

Rob Merrick
Deputy Political Editor
Wednesday 12 July 2017 13:45
Comments
Damian Green, the First Secretary of State, told Prime Minister’s Questions that the ability of UK cancer patients to access medical isotopes produced in Europe would not be affected
Damian Green, the First Secretary of State, told Prime Minister’s Questions that the ability of UK cancer patients to access medical isotopes produced in Europe would not be affected

Theresa May’s deputy has been accused of misleading MPs after insisting cancer patients had nothing to fear from the UK quitting the Euratom agency.

The Nuclear Industry Association (NIA) hit back after Damian Green dismissed doctors’ warnings that radioactive isotopes used in scans and treatments may no longer be available as “scaremongering”.

The Royal College of Radiologists has raised the alarm because the UK lacks reactors to produce the isotopes and relies on imports from France, Germany and Holland, overseen by Euratom.

Half a million scans are performed every year in Britain using imported radioisotopes, and more than 10,000 patients have cancer treatments that use them.

The controversy was raised at Prime Minister’s Questions, where Mr Green – standing in for the absent Ms May, as her effective deputy – attacked “unnecessary worry caused to cancer patients”.

He told MPs: “Euratom places no restrictions on the export of medical isotopes to countries outside the EU.

“So, after leaving Euratom, our ability to access medical isotopes produced in Europe will not be affected.

“I hope that reassures cancer patients around the country that the scaremongering that’s going on is unnecessary.”

But, within minutes, the NIA’s chief executive tweeted a picture of part of the EU treaty which lists medical isotopes among goods “subject to the provision of Chapter 9 on the nuclear common market”.

Tom Greatrex, a former Labour MP, tweeted: “Minister's response on medical isotopes misses point – part of #Euratom common area, listed in Treaty annexe, so are impacted.”

He added: “#euratom matters to both UK and EU - let's deal with this properly. Too important not to.”

The row came as the Government admitted it had not carried out a formal assessment of the impact of quitting the Euratom agency.

A spokeswoman for the Department for Business, Energy and Industrial Strategy told the London Evening Standard: “Although no formal impact assessment was carried out, government did assess the impact; the nuclear industry, the R&D community and the Office for Nuclear Regulation will all confirm this as government is in continuous dialogue with the industry on this.”

Meanwhile, in a Commons debate, no fewer than seven Conservative MPs lined up to urge ministers to think again – enough to defeat the Government, if it comes to a vote.

Without new international agreements to replace it, MPs also fear Britain could run short of materials needed for scientific work and to produce electricity.

One Tory, former minister Bob Neill, warned the Government would be “cutting off your economic and scientific nose to spite your political face”, if it ploughed ahead.

Mr Neill pointed to “very great benefits” to the UK from continued Euratom membership, adding: “We should not allow any thoughts of ideological purity to get in the way of achieving that.”

Significantly, arch-Eurosceptic Sir Bill Cash was also among Conservatives suggesting the UK seeks a form of associate membership of Euratom.

Another Eurosceptic backbencher, Antoinette Sandbach, said the UK had been awarded £500m of contracts in the nuclear fusion supply chain, adding: "All of that is put at risk, is it not, if we leave Euratom.”

The Prime Minister has said Britain will seek a close post-Brexit relationship with the regulator, to try to head off the growing revolt in her party.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in